Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Advanced Hepatocellular Carcinoma
NCT01098760Phase 4Completed
- Sponsor
- Bayer
- Start
- Aug 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Bayer. Started Aug 2010; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01098760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098760.